×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TRUMY – terumo corp unsp/adr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TRUMY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
04:32 pm
trumy
Terumo (TSE:4543): Evaluating Value After Prolonged Share Price Decline [Yahoo! Finance]
Low
Report
Terumo (TSE:4543): Evaluating Value After Prolonged Share Price Decline [Yahoo! Finance]
11/12
09:51 am
trumy
Terumo reports 1H results [Seeking Alpha]
Medium
Report
Terumo reports 1H results [Seeking Alpha]
11/11
12:32 pm
trumy
Interventional Oncology Market to Reach $4.38 Billion by 2030 at CAGR 8.55% - Grand View Research, Inc. [Yahoo! Finance]
Low
Report
Interventional Oncology Market to Reach $4.38 Billion by 2030 at CAGR 8.55% - Grand View Research, Inc. [Yahoo! Finance]
10/30
08:00 am
trumy
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
Low
Report
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
10/29
03:00 pm
trumy
Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025
Low
Report
Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025
10/24
08:00 am
trumy
Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance
Low
Report
Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance
10/22
10:39 am
trumy
The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies
Low
Report
The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies
10/7
01:40 am
trumy
Terumo Blood and Cell Technologies Honored with Corporate Excellence Award at the Asia Pacific Enterprise Awards 2025 Regional Edition [Yahoo! Finance]
Low
Report
Terumo Blood and Cell Technologies Honored with Corporate Excellence Award at the Asia Pacific Enterprise Awards 2025 Regional Edition [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/8
Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A
4.7%
11/28 TERUMO CORP/ADR (OTCMKTS: TRUMY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 3.1%
1/9 MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms 2.3%
8/8 Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A 2.1%
8/9 Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A 0.9%
10/30 TERUMO CORP/ADR (OTCMKTS: TRUMY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 0.6%
11/28 TERUMO CORP/ADR (OTCMKTS: TRUMY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 3.1%
1/9 MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms 2.3%
8/8 Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A 2.1%
8/9 Q1/2020 6/30/2019 EPS 30.150 ZacksConsensus N/A ActVsEst N/A - N/A 0.9%
10/30 TERUMO CORP/ADR (OTCMKTS: TRUMY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 0.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: